Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1

European Journal of Pharmacology

Volumn 578, Issue 2-3, 2008, Pages 171-176

  Fumagalli, Elena ^a   Funicello, Marcella ^a   Rauen, Thomas ^b   Gobbi, Marco ^a   Mennini, Tiziana ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

Cell lines; Glutamate transporter; Riluzole; Synaptosomes; Uptake

Indexed keywords

EAAC1 PROTEIN; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE TRANSPORTER; RILUZOLE; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; EMBRYO; HUMAN; HUMAN CELL; KINETICS; MALE; NEUROPROTECTION; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; CELL LINE; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMIC ACID; HUMANS; KAINIC ACID; KINETICS; MALE; NEUROPROTECTIVE AGENTS; RATS; RILUZOLE; SERINE; SYNAPTOSOMES; TRANSFECTION;

EID: 37349063346     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.10.023     Document Type: Article

References (28)

1. Albo F., Pieri M., and Zona C. Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole. J. Neurosci. Res. 78 (2004) 200-207
2. Aoyama K., Suh S.W., Hamby A.M., Liu J., Chan W.Y., Chen Y., and Swanson R.A. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat. Neurosci. 9 (2006) 119-126
3. Azbill R.D., Mu X., and Springer J.E. Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain Res. 871 (2000) 175-180
4. Bensimon G., Lacomblez L., Meininger V., and ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N. Engl. J. Med. 330 (1994) 585-591
5. Berry C.B., Hayes D., Murphy A., Wiessner M., Rauen T., and McBean G.J. Differential modulation of the glutamate transporters GLT1, GLAST and EAAC1 by docosahexaenoic acid. Brain Res. 1037 (2005) 123-133
6. Bridges R.J., Kavanaugh M.P., and Chamberlin A.R. A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system. Curr. Pharm. Des. 5 (1999) 363-379
7. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65 (2001) 1-105
8. De Sarro G., Siniscalchi A., Ferreri G., Gallelli L., and De Sarro A. NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice. Eur. J. Pharmacol. 408 (2000) 25-34
9. Dunlop J., Beal McIlvain H., She Y., and Howland D.S. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis. J. Neurosci. 23 (2003) 1688-1696
10. Frizzo M.E., Dall'Onder L.P., Dalcin K.B., and Souza D.O. Riluzole enhances glutamate uptake in rat astrocyte cultures. Cell. Mol. Neurobiol. 24 (2004) 123-128
11. Grewer C., and Rauen T. Electrogenic glutamate transporters in the CNS: molecular mechanism, pre-steady-state kinetics, and their impact on synaptic signaling. J. Membr. Biol. 203 (2005) 1-20
12. Heath P.R., and Shaw P.J. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 26 (2002) 438-458
13. Huang C.S., Song J.H., Nagata K., Twombly D., Yeh J.Z., and Narahashi T. G-proteins are involved in riluzole inhibition of high voltage-activated calcium channels in rat dorsal root ganglion neurons. Brain Res. 762 (1997) 235-239
14. Lacomblez L., Bensimon G., Leigh P.N., Guillet P., Meininger V., and Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 347 (1996) 1425-1431
15. Le Liboux A., Lefebvre P., Le Roux Y., Truffinet P., Aubeneau M., Kirkesseli S., and Montay G. Single- and multiple-dose pharmacokinetics of riluzole in white subjects. J. Clin. Pharmacol. 37 (1997) 820-827
16. Lin C.I., Orlov I., Ruggiero A.M., Dykes-Hoberg M., Lee A., Jackson M., and Rothstein J.D. Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature 410 (2001) 84-88
17. Manzoni C., and Mennini T. Arachidonic acid inhibits 3H-glutamate uptake with different potencies in rodent central nervous system regions expressing different transporter subtypes. Pharmacol. Res. 35 (1997) 149-151
18. Martin D., Thompson M.A., and Nadler J.V. The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur. J. Pharmacol. 250 (1993) 473-476
19. Mennini T., Fumagalli E., Gobbi M., Fattorusso C., Catalanotti B., and Campiani G. Substrate inhibitors and blockers of excitatory amino acid transporters in the treatment of neurodegeneration: critical considerations. Eur. J. Pharmacol. 479 (2003) 291-296
20. Mim C., Balani P., Rauen T., and Grewer C. The glutamate transporter subtypes EAAT4 and EAATs 1-3 transport glutamate with dramatically different kinetics and voltage dependence but share a common uptake mechanism. J. Gen. Physiol. 126 (2005) 571-589
21. Noh K.M., Hwang J.Y., Shin H.C., and Koh J.Y. A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C. Neurobiol. Dis. 7 (2000) 375-383
22. Rauen T., Jeserich G., Danbolt N.C., and Kanner B.I. Comparative analysis of sodium-dependent l-glutamate transport of synaptosomal and astroglial membrane vesicles from mouse cortex. FEBS Lett. 312 (1992) 15-20
23. Rothstein J.D., Martin L.J., and Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326 (1992) 1464-1468
24. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., and Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38 (1995) 73-84
25. Urbani A., and Belluzzi O. Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur. J. Neurosci. 12 (2000) 3567-3574
26. Wang S.J., Wang K.Y., and Wang W.C. Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes). Neuroscience 125 (2004) 191-201
27. Wokke J. Riluzole. Lancet 348 (1996) 795-799
28. Zona C., Siniscalchi A., Mercuri N.B., and Bernardi G. Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons. Neuroscience 85 (1998) 931-938